Hims & Hers launches GLP-1 drug shortage tracker (NYSE:HIMS)


Two packages of 5 dosing pens each of a fictitious Semiglutin drug used for weight loss (antidiabetic medication or anti-obesity medication) on a blue transparent background. Fictitious package design

aprott

Hims & Hers (NYSE:HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular weight-loss drugs are in short supply.

The company said around 80,000 users of the tracker have reported they were unable


Leave a Comment